# Promoting Recovery After STroke With Amantadine

> **NCT05140148** · PHASE2 · RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 60 (estimated)

## Conditions studied

- Stroke, Ischemic
- Stroke Hemorrhagic

## Interventions

- **DRUG:** Amantadine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05140148
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05140148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05140148, "Promoting Recovery After STroke With Amantadine". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05140148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*